L. Tye
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 24
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Diagnosis and Treatment 4
- Oncology 17
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 5
- Co-authors
- Richard C. Chao (19 shared papers)Mark A. Socinski (9 shared papers)Neal J. Meropol (4 shared papers)Matthew H. Kulke (3 shared papers)Xin Huang (3 shared papers)Ramaswamy Govindan (7 shared papers)Paulina Selaru (5 shared papers)Heinz‐Josef Lenz (3 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (5 papers)British Journal of Cancer (3 papers)Pediatric Research (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
L. Tye
41 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 66
- Oncology 860
- Pulmonary and Respiratory Medicine 847
- Neurology 274
- Epidemiology 448
- Cancer Research 195
Countries citing papers authored by L. Tye
This map shows the geographic impact of L. Tye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Tye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Tye more than expected).
Fields of papers citing papers by L. Tye
This network shows the impact of papers produced by L. Tye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Tye. The network helps show where L. Tye may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Tye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 456 | |
| 2 | 2008 | 275 | |
| 3 | 2014 | 200 | |
| 4 | 2012 | 173 | |
| 5 | 2009 | 110 | |
| 6 | 2012 | 104 | |
| 7 | 2013 | 51 | |
| 8 | 2013 | 47 | |
| 9 | 2010 | 41 | |
| 10 | 2006 | 38 | |
| 11 | 2015 | 37 | |
| 12 | 2007 | 36 | |
| 13 | 2009 | 32 | |
| 14 | Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. | 1995 | 32 |
| 15 | 2012 | 21 | |
| 16 | 2013 | 18 | |
| 17 | 2000 | 18 | |
| 18 | 2012 | 16 | |
| 19 | 1999 | 13 | |
| 20 | 1980 | 12 |
About L. Tye
L. Tye is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Clinical Biochemistry and Genetics, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (7 papers), Cancer Treatment and Pharmacology (5 papers), Metabolism and Genetic Disorders (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Estrogen and related hormone effects (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Oncology (860 citations), Pulmonary and Respiratory Medicine (847 citations), Neurology (274 citations), Epidemiology (448 citations) and Cancer Research (195 citations). L. Tye has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Richard C. Chao, Mark A. Socinski, Neal J. Meropol, Matthew H. Kulke, Xin Huang, Ramaswamy Govindan, Paulina Selaru, Heinz‐Josef Lenz, Charles M. Baum and David P. Ryan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Pediatric Research and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.